Vitamin C is effective for the prevention and regression of endometriotic implants in an experimentally induced rat model of endometriosis

Taiwanese Journal of Obstetrics and Gynecology

Volumn 55, Issue 2, 2016, Pages 251-257

  Erten, Ozlem Ulas ^a   Ensari, Tuğba Altun ^b   Dilbaz, Berna ^b   Cakiroglu, Huseyin ^c   Altinbas, Sadiman Kiykac ^b   Çaydere, Muzaffer ^d   Goktolga, Umit ^b  

^a Department of Orthopaedic Surgery   (Turkey)

^b Clinic of Reproductive Endocrinology and Infertility Ankara Etlik Zübeyde Han m Women s Health Education and Research Hospital   (Turkey)

^c Pendik Veterinary Control Institute   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Endometriotic implant; Rat model; Regression; Vitamin C; Volume

Indexed keywords

ASCORBIC ACID; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIOTIC IMPLANT; FEMALE; GYNECOLOGICAL AND OBSTETRIC IMPLANT; HISTOPATHOLOGY; LAPAROTOMY; NONHUMAN; PROSPECTIVE STUDY; RAT; WEIGHT CHANGE; ANIMAL; DISEASE MODEL; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; PROSPECTIVE STUDIES; RATS; RATS, WISTAR;

EID: 84963680014     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2015.07.004     Document Type: Article

References (34)

1. Matarese G., De Placido G., Nikas Y., Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med 2003, 9:223-228.
2. Crosignani P., Olive D., Bergqvist A., Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update 2006, 12:179-189.
3. Amsterdam L.L., Gentry W., Jobanputra S., Wolf M., Rubin S.D., Bulun S.E. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005, 84:300-304.
4. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364:1789-1799.
5. Gauché-Cazalis C., Koskas M., Cohen Scali S., Luton D., Yazbeck C. Endometriosis and implantation: myths and facts. Middle East Fertil Soc J 2012, 17:79-81.
6. Paul Dmowski W., Braun D.P. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 2004, 18:245-263.
7. Seli E., Berkkanoglu M., Arici A. Pathogenesis of endometriosis. Obstet Gynecol Clin North Am 2003, 30:41-61.
8. Prieto L., Quesada J.F., Cambero O., Pacheco A., Pellicer A., Codoceo R., et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril 2012, 98:126-130.
9. Ruder E.H., Hartman T.J., Blumberg J., Goldman M.B. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update 2008, 14:345-357.
10. Peltomaki P., Butzow R. Endometriosis as an epigenetic disease. Epigenomics 2011, 3:690-691.
11. Van Langendonckt A., Casanas-Roux F., Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002, 77:861-870.
12. Gonzalez-Ramos R., Defrere S., Devoto L. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil Steril 2012, 98:520-528.
13. Gonzalez-Ramos R., Rocco J., Rojas C., Sovino H., Poch A., Kohen P., et al. Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients. Fertil Steril 2012, 97:645-651.
14. Santanam N., Kavtaradze N., Murphy A., Dominguez C., Parthasarathy S. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Transl Res 2013, 161:189-195.
15. Du J., Cullen J.J., Buettner G.R. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 2012, 1826:443-457.
16. Lane D.J., Lawen A. Ascorbate and plasma membrane electron transport-enzymes vs efflux. Free Radic Biol Med 2009, 47:485-495.
17. Berger T.M., Polidori M.C., Dabbagh A., Evans P.J., Halliwell B., Morrow J.D., et al. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 1997, 272:15656-15660.
18. Cameron E., Pauling L., Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res 1979, 39:663-681.
19. Mikirova N.A., Ichim T.E., Riordan N.H. Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med 2008, 6:50.
20. Yeom C.H., Lee G., Park J.H., Yu J., Park S., Yi S.Y., et al. High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med 2009, 7:70.
21. Verrax J., Calderon P.B. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med 2009, 47:32-40.
22. Chen P., Stone J., Sullivan G., Drisko J.A., Chen Q. Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models. Free Radic Biol Med 2011, 51:681-687.
23. Grümmer R. Animal models in endometriosis research. Hum Reprod Update 2006, 12:641-649.
24. Malik E., Meyhöfer-Malik A., Berg C., Böhm W., Kunzi-Rapp K., Diedrich K., et al. Fluorescence diagnosis of endometriosis on the chorioallantoic membrane using 5-aminolaevulinic acid. Hum Reprod 2000, 15:584-588.
25. Vernon M.W., Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985, 44:684-694.
26. Durak Y., Kokcu A., Kefeli M., Bildircin D., Celik H., Alper T. Effect of vitamin C on the growth of experimentally induced endometriotic cysts. J Obstet Gynaecol Res 2013, 39:1253-1258.
27. Uygur D., Aytan H., Zergeroglu S., Batioglu S. Leflunomide-an immunomodulator-induces regression of endometrial explants in a rat model of endometriosis. J Soc Gynecol Investig 2006, 13:378-383.
28. Guney M., Nasir S., Oral B., Karahan N., Mungan T. Effect of caffeic acid phenethyl ester on the regression of endometrial explants in an experimental rat model. Reprod Sci 2007, 14:270-279.
29. Keenan J.A., Williams-Boyce P.K., Massey P.J., Chen T.T., Caudle M.R., Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 1999, 72:135-141.
30. Masson P.J. Trichrome stainings and their preliminary techniques. J Tech Met 1929, 12:75.
31. Anaf V., Simom P.H., El Nakadi I. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000, 15:1744-1750.
32. Fedele L., Somigliana E., Frontino G., Benaglia L., Vigano P. New drugs in development for the treatment of endometriosis. Expert Opin Investig Drugs 2008, 17:1187-1202.
33. Mier-Cabrera J., Aburto-Soto T., Burrola-Mendez S., Jimenez-Zamuido L., Tolentino M.C., Casanueva E., et al. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol 2009, 7:54.
34. Brown J., Pan A., Hart R.J. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2010, 12:CD008475.